Drugs / BIOBYPASS®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00215696 | Apr 2005 → ? | intermediate coronary syndrome | GenVec | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIOBYPASS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00215696 ↗ |
| Known as | ADGVVEGF121.10NH | “A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of BIOBYPASS® (ADGVVEGF121.10NH) Delivered by NOGA™-GUIDED/MYOSTAR™ Catheter in "No...” NCT00215696 ↗ |
| Route | Other | “Delivered by NOGA™-GUIDED/MYOSTAR™ Catheter” NCT00215696 ↗ |